Spots Global Cancer Trial Database for Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
Official Title: Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
Study ID: NCT05773144
Conditions
Study Description
Brief Summary: To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kaiser Permanente Northern California, Oakland, California, United States
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact Details
Name: Justin C. Brown, Ph.D.
Affiliation: Pennington Biomedical Research Center
Role: PRINCIPAL_INVESTIGATOR
Name: Jeffrey A. Meyerhardt, M.D., M.P.H.
Affiliation: Dana-Farber Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Name: Bette J. Caan, Dr.P.H.
Affiliation: Kaiser Permanente
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
